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Abstract 
 
While  many  have  identified  medication  adherence  as  a 
critical  part  of  therapy  success  and  recognize  that  most 
therapies  have  adherence  rates  that  are  too  low,  few 
successful solutions to improve adherence have emerged. 
The palette of potential adherence interventions continues 
to  grow,  but  the  literature  does  not  provide  a  general 
understanding  of  what  works  and  what  doesn’t.  Instead, 
many papers describe adherence problems within a single 
condition,  therapy,  or  patient  population  or  assess 
traditional interventions: support phone calls, informational 
literature,  reminder  text  messages.  Furthermore,  the 
specifics of adherence approaches tested are not typically 
discussed  in  the  literature.    One  can  imagine  multiple 
telephonic “support” experiences, some of which motivate 
and  truly  support  patients,  and  others  which  may  annoy 
them. The missing piece is an approach to adherence that 
considers  design.  A  more  careful  consideration  of  the 
details of the design will open new possibilities for effective 
adherence  intervention  systems.  Understanding  the 
broader context of design: the particular condition, therapy, 
and patient population, will help ensure that those details 
are most appropriate. The combined focus on details with 
sensitivity  to  context  creates  a  foundation  for  innovation 
that can be both customized to the particular problem and 
generalizable for other researchers and designers. 
 
 
Why is adherence a problem?  
One reason why healthcare costs so much and yet isn’t as 
effective  as  we’d  like  is  the  problem  of  medication 
adherence.  When  patients  are  adherent,  they  take  their 
therapies  correctly,  on  the  right  schedule,  and  for  the 
prescribed duration – however many patients fail at one or 
all of these. As a result, pharmaceutical companies spend 
huge development budgets
1 to create efficacious drugs that 
doctors invest in learning about and insurance companies 
spend millions paying for, that people fail to take. Patients 
don’t  get  needed  treatment  or  may  miss  out  on  the 
opportunity to prevent or delay disease, leading to more 
 
 
 
 
 
 
 
 
expensive  care  later  on.  Today,  most  approaches  to 
addressing medication adherence problems are failing.  
 
It is time for a new way of thinking about adherence—one 
that  is  centered  on  patients  and  their  needs.  By 
understanding adherence as an integrated design problem, 
interventions  can  be  targeted  to  solve  critical  challenges. 
Currently, many articles in medication adherence focus on 
documenting  poor  adherence  and  intervention  trials  and 
discussing methodologies for measuring adherence.  While 
this is understandable in a field with a messy problem where 
measurement  is  difficult,  this  focus  has  been  to  the 
detriment of designing successful adherence interventions. 
Detailed  attention  should  be  paid  to  the  design  of 
adherence  interventions  so  that  they  –  like  adherence 
measurement methodologies -- can be refined over time. 
 
More broadly, adherence, loyalty, and retention are terms 
applied to consistently doing something over time to derive 
a benefit. In many cases, this benefit only accrues with time 
and continued use. Inspiration for designing for medication 
adherence  can  be  found  in  other  industries  where 
adherence matters. Whether in consumer health, financial, 
or other services, there are customer/consumer retention 
programs that are working. These analogous examples can 
be mined for successful adherence solutions. While not all 
such  interventions  are  suited  to  healthcare,  insights  can 
spring  from  taking  a  broader  view  of  adherence  and 
adherence interventions. Understanding the root causes of 
adherence  failure  is  the  first  step  towards  designing 
successful interventions. 
 
What causes Adherence failures? 
Articles  on  adherence  (i.e.  defined  more  broadly  than 
medication adherence) can be found in journals focusing on 
business, marketing, psychology, and medicine/healthcare, 
all commonly diagnosing one or more root problems:  
The problem is people 
The problem is the system 
The problem is instructions 
The problem is reminders 
Most  articles  focus  on  a  single  type  of  problem,  such  as 
pharmacy loyalty, rental-car customer loyalty, adherence in 
diabetes,  or  blood  donor  retention.  Other  articles  cross 
several problem types focusing on single underlying causes, 
such as human motivation. This paper reviews the range of 
root-cause diagnoses to show that all merit consideration, 
but  some  are  more  useful  for  the  design  of  effective 
interventions.  
 
The problem is people 
“The bad patient.” Physicians often believe, “If I tell them to 
take  it,  they  will!”  Then  they  are  shocked  when  patients 
The forest and the trees: An integrated approach to designing adherence 
interventions  
 
 
Devorah E. Klein  
IDEO, Cambridge, MA 
Corresponding Author: 
Devorah Klein 
IDEO 
Cambridge, MA 
dklein@ideo.com   Australasian Medical Journal 2009, 1, 13, 181-184 
 
             182 
disobey
2.  This  perspective  highlights  frustration  with 
patients,  but  has  yielded  a  call  for  more  physician 
involvement in fostering patient adherence
3.  
 
 “The  conflicted  customer.”  Psychologists  and 
anthropologists  also  see  the  locus  of  the  problem  in  the 
individual.  These  professionals  may  focus  on  underlying 
emotional  issues,  a  search  for  novelty,  or  a  lack  of  self-
efficacy  as  the  root  cause.  The  resulting  solutions  try  to 
change beliefs or tailor approaches
4-6. While important to 
understand,  the  problem  of  personality  change  is 
overwhelming as an intervention.  
 
“The unmotivated consumer.” Patients’ drug costs certainly 
affect adherence
7 , but eliminating costs doesn’t solve the 
problem.  The  world  of  business  and  business  consulting 
often views consumers as relatively averse to change and 
primarily financially motivated
8. They reward consumers for 
sticking  with  a  service  (“pay  for  three  months,  get  the 
fourth free”) or try to discourage potentially non-adherent 
consumers  from  initiating  in  the  first  place  in  order  to 
improve  apparent  adherence  rates.  Rewarding  behaviour 
with money can serve to devalue intrinsic benefits, creating 
even higher barriers to long-term adherence. 
 
The problem is the system 
Inadequate  attention.    Some  articles  argue  that  if  nurses 
and  physicians  had  more  time  with  patients,  they  could 
educate them about the importance of adherence and help 
them find viable solutions
9. While more attention and time 
could  only  help,  this  solution  is  difficult  to  implement  in 
today’s healthcare environment.  
 
Impossible  economics.  Researchers  find  that  some  high-
intensity programs involving daily calls and/or personalized 
counselling are successful, but they come with a prohibitive 
pricetag
10.  Handholding  interventions  may  also  reduce 
patients’ self-sufficiency.  
 
Pharmacists  as  providers.  There  are  several  examples  of 
successful programs in which pharmacists are filling a void 
in adherence counseling
11. This approach is a component of 
an effective intervention, but likely insufficient on its own. 
 
The problem is the instructions 
Researchers who blame the instructions focus on ignorance 
of how to follow the plan and what to expect. Some have 
legitimately  criticized  the  quality  of  the  instructions
12,13. 
However,  better  instructions  alone  will  not  solve  the 
problem. 
 
The problem is reminders 
If  people  are  monitored  and  given  feedback,  perhaps 
adherence  can  improve.  Reminding  programs  range  from 
emails  or  printed  letters  to  devices  that  emit  sounds  or 
flashing lights to alert the user of a missed dose. The latter 
approach  is  buoyed  by  the  technological  possibilities  of 
electronic  packaging  that  can  more  explicitly  remind 
patients
14.  Used  alone,  reminding  can  be  perceived  as 
annoying  or  patronizing.  Within  an  integrated  system, 
gentle reminders can be quite helpful. 
 
Solutions Tried 
Articles  comparing  adherence  solutions  are  plentiful. 
However,  the  comparisons  are  always  at  the  level  of 
solution  classes—primary  or  secondary  packaging, 
educational material, reminding tools (digital and analogue), 
MEMS  (Medication  Event  Monitoring  System),  counselling 
(in person or by phone), etc.—and rarely, if ever, describe 
the  details  of  design  execution.  Even  one  of  the  most 
thorough examinations to date
14 only describes the classes 
of solutions, without illustration. In a cursory review of  9 
meta-analyses of intervention efficacy, only three
15-17 spend 
roughly  the  same  space  describing  interventions  as  they 
spend describing the methods for statistical analysis.  
 
Despite the paucity of attention, the details of design can 
drive  an  intervention’s  success.  For  example,  the  blanket 
group  “packaging  interventions”  varies  tremendously  in 
labelling,  ease  of  use,  size,  and  reminding  cues.  A  birth 
control pill package, Advair diskus, and a Target pill bottle (a 
new container and label design created by a U.S. pharmacy 
chain)  are  highly  differentiated.  For  telephone  reminding 
interventions,  the  frequency,  prompting  (do  patients  or 
callers  set  the  time?),  tone,  and  script  all  impact  the 
experience.  Educational  materials  can  range  widely. 
Consider the difference between a doctor’s office pamphlet, 
a diet infomercial, and the website cnn.com, and it becomes 
easy  to  understand  how  the  specifics  of  an  educational 
piece can determine desirability, usability, and efficacy. 
 
Most  current  research  is  directed  at  creating,  evaluating, 
and  refining  very  limited  features  of  adherence 
measurement  techniques  and  evaluating  single-pronged 
interventions  (likely  due  to  complexity  and  budget-
constraints),  rather  than  assessing  how  integrated 
interventions fare in real-world contexts. 
 
Case study  
Weight Watchers has built a successful business around one 
of  the  toughest  perennial  adherence  challenges:  losing 
weight.  They’ve  done  so  through  iteration  and  taking  an 
integrated approach to intervention design.  
 
Weight loss is difficult for most people because there are 
myriad  problems:  dieters  may  have  low  self-efficacy  and 
unrealistic goals; a poor understanding of how diets work 
and  what  calories  mean;  little  knowledge  of  the  rules  of 
healthy  eating;  poor  cues  to  prompt  them  to  make  good 
decisions  in  the  moment;  and  little  immediate  feedback. 
Many people come with experiences of failing on numerous 
diet plans.  
 
The  current  iteration  of  the  Weight  Watchers  system 
addresses this cornucopia of confusion with an integrated 
system  of  interventions.  There  are  online  quizzes  to  help 
assess  whether  people  are  realistic  in  their  goals  (see 
www.weightwatchers.com  for  more  details)  and  ready  to 
make  a  change.  To  help  clarify  how  to  diet  and  address 
individual differences, Weight Watchers offers plans based 
on two distinct mental models of how people choose to eat: 
unlimited  quantities  from  a  limited  list  of  options,  or  Australasian Medical Journal 2009, 1, 13, 181-184 
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unlimited  options  in  limited  quantities.  Weight  Watchers 
acknowledges the temptation to cheat by incorporating Flex 
points, which can be used outside of regular meals either 
for a daily treat or saved up for a weekly splurge. While 
there  are  options  for  online  Weight  Watchers,  in-person 
weekly meetings are a critical place to see progress and get 
feedback. 
 
This  integrated  systems  approach  continues  to  work  for 
consumers, and Weight Watchers remains one of the more 
successful commercial weight loss programs
18. 
 
Taking an integrated design approach to adherence  
The problem types discussed initially share a fairly narrow 
attribution of reasons for non-adherence; few have led to 
interventions  that  are  successful,  scalable,  and  cost-
effective
19.  Taking  the  perspective  of  adherence  as  an 
integrated design opportunity
20 lets us consider an entire 
network  of  involved  stakeholders  (patients,  caregivers, 
HCPs, pharmacists, payers, and therapy manufacturers) and 
multiple touch points, i.e.,  moments of interaction between 
the patient and the adherence support system. In addition, 
this  perspective  treats  interventions  as  meriting  detailed 
study. 
 
What  is  integrated  design  for  adherence?  It  means 
designing more than a single intervention (such as better 
reminding).  It  means  designing  to  more  than  a  blanket 
diagnosis  (“people  won’t  be  adherent  without  external 
rewards”). Taking an integrated design approach requires a 
commitment  to  choreograph  each  step  and  design  detail 
into a complete, supportive experience, where every aspect 
works together. It requires constant attention to the details 
of design along with the context of the adherence problem. 
As an experience, it must evolve over time to support the 
changing  needs  of  the  patients  and  respond  to  them  as 
their relationship with the therapy evolves. The steps of the 
process are to: 
Understand the patients 
Understand the problem 
Explore the solution space 
Design to fit 
Integrated design assumes no single intervention will work 
for  all  therapies.  Design  can  vary  based  on  the  patient 
population,  condition,  therapy,  and  array  of  potential 
intervention  components.  To  fully  understand  these  may 
require an in-depth look at the patients and their contexts, 
though  interviews  and  observations  in  their  homes  and 
everyday lives outside clinical settings. Such research may 
yield  results  that  are  surprising  to  physicians,  and  at  the 
very least, useful for augmenting physicians' understandings 
of patients and their needs. For example, the number of 
patients  who  split  pills  or  otherwise  change  dosing  to 
address side effect concerns surprises many physicians. 
 
Understand  the  patients.  It  is  critical  to  understand  a 
condition’s distinct population to design successfully. How 
can they be characterized physically (abilities, limitations), 
mentally, cognitively, emotionally, socially, and financially? 
What  makes  them  unique?  Will  their  needs  change  over 
time? 
 
Understand  the  problem.  What  makes  this  condition 
distinctive? What burdens does it impose on patients? How 
does the therapy work? What does it require of patients? 
What  makes  adherence  hard  for  them?  Where  do  they 
struggle? 
 
Explore the solution space. Next, what are the design levers? 
In  the  highly  regulated  world  of  healthcare,  fewer  design 
components are available than in the consumer world. To 
design  an  implementable  system,  the  palette  of  possible 
interventions must be mapped.  
 
Design  to  fit.  Now  the  design  process  can  begin.  Decide 
which channels (tools, educational materials, services, etc.) 
should be used and when. Decide which stakeholders to use 
when  (LPNs  and  pharmacists  remain  particularly 
underutilized). Should the intervention change over time? 
Select  the  critical  touch  points  to  hit.  Set  the  tone  at 
different touch points. Craft the design details to fit. 
 
The design world has long recognized how much the details 
matter
21. The iPod shared the same basic functionality as 
preceding  MP3  players,  but  the  specific  details  of  its 
execution set it apart. Like dozens of other diets, Weight 
Watchers  is  grounded  in  basic  calorie  counting,  but  is 
distinguished  in  the  way  it  simplifies  the  task  and  offers 
support.  The  details  matter.  Thoughtful  design  means 
considering shapes, colours, tone, font, phrasing, and critical 
interaction touch points in parallel with continually building 
on  input  from  critical  stakeholders—patients,  clinicians, 
pharmacists,  family  members,  and  others—to  arrive  at  a 
refined solution.  
 
Most  adherence  efforts  to-date  remain  a  collection  of 
unrelated  interventions.  For  example,  a  solution  might 
include text messages and adherence packaging. These are 
useful features; yet, an ad-hoc handful of interventions fails 
to  create  a  unified  system,  and  hardly  realizes  their 
potential  value.  Weight  Watchers  benefits  not  from 
individual features (none of which are unique) but from the 
way these features are integrated. An integrated system of 
interventions is more powerful than the sum of its parts.  
 
To achieve an integrated design approach, research reports 
need to describe the details of interventions so that other 
researchers can evaluate, iterate, and build on prior work. 
Doing so will enable thoughtful design for adherence. 
 
Conclusions  
Achieving  adherence  has  long  bedevilled  healthcare. 
Researchers  and  clinicians  have  historically  focused  on 
narrow  interventions  rather  than  integrated  design 
approaches. Evaluating solution classes without studying the 
design  details  will  keep  us  from  learning  what  makes 
interventions effective. By shifting our focus to interventions 
as a field of study we can increase the probability of creating 
successful  systems  of  adherence  interventions.  To  build 
long-term adherence, researchers need to regard adherence 
design as an important area of inquiry, study the details, and  Australasian Medical Journal 2009, 1, 13, 181-184 
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bring  a  systems  perspective  to  designing  integrated 
adherence interventions.   
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